Compare Manulife Financial Corporation (MFC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manulife Financial Corporation vs Zoetis Inc — how do they compare? Manulife Financial Corporation trades at $42.43 (market cap $69.48B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Manulife Financial Corporation is far larger — about 2.3× Zoetis Inc's market cap, and Manulife Financial Corporation pays the higher dividend (3.23%). Which is the better fit depends on your goals — on Pluang, investors hold Manulife Financial Corporation for 119 Days and Zoetis Inc for 70 Days on average.
| MFC | ZTS | |
|---|---|---|
Market Cap | $69.48B | $30.20B |
Volume | 1,347,508 | 6,175,327 |
Sector | Financials | Health |
52-Week High | $44.77 | $147.53 |
52-Week Low | $31.64 | $69.09 |
Typical Hold Time | 119 Days | 70 Days |
Enterprise Value | $64.75B | $37.76B |
Dividend Yield | 3.23% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MFC trades at $42.12, up 1.08% today, with a bearish technical signal from moving averages. Revenue grew to $53.01B in 2025, with a net income margin of 11.7%, while Q2 2026 earnings beat expectations. Analyst consensus is bullish with 57% buy ratings, though the consensus price target of $34.24 is below the current price. Recent news includes a new $750M subordinated notes offering and executive appointments.
Outlook is mixed: strong fundamentals and institutional interest support upside, but technical weakness and a high valuation relative to the price target pose risks. Key catalysts include Q3 2026 earnings and execution of growth initiatives in Asia.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
